AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25708818
Drug: Prednisolone treatment
RxNorm normalized name: Prednisolone
DrugBank: Prednisolone acetate (DB15566)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisolone treatment (control group)
Trial: 10383546
Drug: WAG 994
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WAG 994 1 mg
Trial: 8558223
Drug: Interferon alfa-2b
RxNorm normalized name: Interferon Alfa-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2b (IFN alpha-2b) administered at 20 MU/m2/d intravenously for 1 month and 10 MU/m2 three times per week subcutaneously for 48 weeks
Trial: 6348227
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of amikacin 7.5 mg/kg intramuscularly
Trial: 6348227
Drug: Sulfisoxazole 150
RxNorm normalized name: sulfisoxazole 150 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfisoxazole 150 mg/kg/day orally for 10 days
Trial: 29146124
Drug: Canakinumab 50
RxNorm normalized name: Canakinumab
DrugBank: Canakinumab (DB06168)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Canakinumab 50 mg
Trial: 29146124
Drug: Canakinumab 300
RxNorm normalized name: Canakinumab
DrugBank: Canakinumab (DB06168)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Canakinumab 300 mg
Trial: 24114811
Drug: AG013 (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AG013 (oral rinse containing recombinant Lactococcus lactis secreting hTFF1)
Trial: 19349543
Drug: Irinotecan plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irinotecan plus cisplatin (IP) - irinotecan 60 mg/m² on days 1, 8, and 15; cisplatin 60 mg/m² day 1, every 4 weeks
Trial: 19349543
Drug: Etoposide plus
RxNorm normalized name: Etoposide
DrugBank: Etoposide (DB00773)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Etoposide plus cisplatin (EP) - etoposide 100 mg/m² on days 1 through 3; cisplatin 80 mg/m² day 1, every 3 weeks
Trial: 15479311
Drug: Target-controlled propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Target-controlled propofol infusion
Trial: 15479311
Drug: Manual propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Manual propofol infusion
Trial: 11528490
Drug: Oral dose
RxNorm normalized name: Exactamed Oral Dose Syringe 35cc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral dose of iodized oil, containing 540 mg I
Trial: 11367648
Drug: Xinmaitong (XMT)
RxNorm normalized name: XMT-2056
DrugBank: XMT-2056 (DB18230)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xinmaitong (XMT) capsule
Trial: 11367648
Drug: Conventional western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional western medical therapy
Trial: 7583724
Drug: Helical CT
RxNorm normalized name: CT-179
DrugBank: CT-179 (DB17114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Helical CT with monophasic injections of contrast agent at 3 mL/second
Trial: 7583724
Drug: Conventional CT
RxNorm normalized name: CT-179
DrugBank: CT-179 (DB17114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional CT with biphasic injections at 2 and 0.7 mL/second
Trial: 1976782
Drug: (+/‐)‐propranolol base
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (+/‐)‐propranolol base (0.108 mg kg‐1 of ideal body weight)
Trial: 1976782
Drug: (+/‐)‐sotalol base
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (+/‐)‐sotalol base (1.06 mg kg‐1 of ideal body weight)
Trial: 21623389
Drug: Combined infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined infusion of propofol and remifentanil
Trial: 12724021
Drug: Hormone Replacement
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone Replacement Therapy (HRT) with ten different estrogen or estrogen‐progestin molecules, regimens and routes of administration
Trial: 12724021
Drug: HRT with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT with progestin molecules (except for 19‐nor derivatives) added to transdermal estradiol administration
Trial: 7860905
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of amlodipine and atenolol
Trial: 1424937
Drug: Generalized decision
RxNorm normalized name: celecoxib
DrugBank: Celecoxib (DB00482)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Generalized decision tree or clinical algorithm for treatment
Trial: 3909587
Drug: Conventional immunosuppressive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional immunosuppressive therapy (azathioprine and steroids)
Trial: 3909587
Drug: Cyclosporin A
RxNorm normalized name: Cyclosporin A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin A combined with steroids
Trial: 30393955
Drug: Intensive statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive statin therapy targeting LDL cholesterol <1.81 mmol/L
Trial: 30393955
Drug: Standard statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard statin therapy targeting LDL cholesterol ≥2.59 to <3.10 mmol/L
Trial: 21538074
Drug: Long-term oral
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term oral appliance use
Trial: 20129008
Drug: 2-day educational
RxNorm normalized name: DIABETES PATIENT EDUCATION PACK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-day educational seminar and monthly group guidance for 6 months
Trial: 12059059
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of FS and faecal occult blood test (FOBT)
Trial: 9864836
Drug: TNFR55-IgG1 (2.5-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TNFR55-IgG1 (2.5-100 mg/month, given i.v., cumulative doses from 40-940 mg)
Trial: 8589768
Drug: casein-soy VLED
RxNorm normalized name: caseins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: casein-soy VLED (96 g protein, 1.7 MJ/d)
Trial: 2184790
Drug: Physician recognition
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Physician recognition of depression (defined by chart notation or prescription of antidepressants)
Trial: 6965176
Drug: Cognitive family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive family therapy
Trial: 29166854
Drug: Ringer's lactate
RxNorm normalized name: Ringer's lactate/gel dressing 2.2" TOPICAL KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer's lactate 10 mL containing dezocine 0.1 mg/kg (Group D)
Trial: 29166854
Drug: Ringer's lactate
RxNorm normalized name: Ringer's lactate/gel dressing 2.2" TOPICAL KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ringer's lactate 10 mL (Group C)
Trial: 26076191
Drug: Octreotide s.c.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide s.c. depot A 10, 20 or 30 mg, B 30 mg, C 10, 20 or 30 mg
Trial: 26731483
Drug: Octreotide LAR
RxNorm normalized name: octreotide LAR 20 MG Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Octreotide LAR 30 mg
Trial: 19266107
Drug: Flavored supplement
RxNorm normalized name: blackberry flavor
DrugBank: Blackberry (DB10628)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flavored supplement (Group 1)
Trial: 19266107
Drug: Non-flavored (neutral)
RxNorm normalized name: blackberry flavor
DrugBank: Blackberry (DB10628)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-flavored (neutral) supplement (Group 2)
Trial: 19266107
Drug: Kitchen foods
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Kitchen foods as supplements (Group 3)
Trial: 17056206
Drug: Medication coaching
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication coaching plus voucher reinforcement for opening electronic medication caps on time
Trial: 17056206
Drug: Medication coaching
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication coaching sessions every other week (comparison group)
Trial: 15377466
Drug: G‐CSF 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF 5 micro g/kg/day (group A)
Trial: 15377466
Drug: G‐CSF 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G‐CSF 10 micro g/kg/day (group B)
Trial: 9863077
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of artesunate tablet over 3 days
Trial: 9863077
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of artesunate tablet over 5 days
Trial: 9863077
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg of artesunate tablet over 7 days
Trial: 7910560
Drug: Somatostatin-28 (S-28)
RxNorm normalized name: Somatostatine
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin-28 (S-28) infusion
Trial: 7910560
Drug: Somatostatin-14 (S-14)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin-14 (S-14) infusion
Trial: 3302248
Drug: d,alpha-tocopherol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: d,alpha-tocopherol (400 IU daily for three cycles)
Trial: 18443980
Drug: Antipsychotic medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antipsychotic medication (typical or atypical)
Trial: 7048880
Drug: Pindolol 60
RxNorm normalized name: Pindolol
DrugBank: Pindolol (DB00960)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pindolol 60 mg
Trial: 7048880
Drug: Pindolol (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pindolol (mean dose 50 mg/day)
Trial: 7048880
Drug: Propranolol (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (mean 360 mg/day)
Trial: 7048880
Drug: Chlorthalidone (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone (mean 107 mg/day)
Trial: 23711593
Drug: Miglitol and
RxNorm normalized name: Miglitol
DrugBank: Miglitol (DB00491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Miglitol and Mitiglinide combination
Trial: 9784769
Drug: Prophylactic epoetin
RxNorm normalized name: Epoetin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic epoetin alfa therapy
Trial: 3073077
Drug: Nifedipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (10 mg three times/day)
Trial: 3073077
Drug: Atenolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atenolol (100 mg) plus Nifedipine (10 mg three times/day)
Trial: 24827384
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (Control Group B)
Trial: 16781360
Drug: eptifibatide +
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: eptifibatide + reduced dose unfractionated heparin (n = 298)
Trial: 16781360
Drug: eptifibatide +
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: eptifibatide + reduced-dose enoxaparin (n = 275)
Trial: 16781360
Drug: bivalirudin monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bivalirudin monotherapy (n = 284)
Trial: 14586603
Drug: Intensive rehabilitative
RxNorm normalized name: Uricalm Intensive
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive rehabilitative treatment for 14 days
Trial: 14586603
Drug: Ordinary rehabilitative
RxNorm normalized name: ordinary salt combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ordinary rehabilitative treatment for 14 days
Trial: 11056254
Drug: Saline infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusion hysterosonography (SIS)
Trial: 11056254
Drug: Hysterosalpingography (HSG)
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hysterosalpingography (HSG) and Saline infusion hysterosonography (SIS)
Trial: 11056254
Drug: Outpatient hysteroscopy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient hysteroscopy (OHS) and Saline infusion hysterosonography (SIS)
Trial: 8816211
Drug: Bovine surfactant
RxNorm normalized name: Pegademase Bovine
DrugBank: Pegademase (DB00061)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bovine surfactant (cumulative phospholipid dose of 200 mg/kg)
Trial: 8816211
Drug: Bovine surfactant
RxNorm normalized name: Pegademase Bovine
DrugBank: Pegademase (DB00061)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bovine surfactant (single dose of 100 mg/kg)
Trial: 1409770
Drug: Eicosapentaenoic acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) supplementation (10 mg, 100 mg, 1000 mg, 10,000 mg EPA daily; 3 mg, 33 mg, 333 mg, 3333 mg DHA)
Trial: 26327799
Drug: Pre-operative ibuprofen
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pre-operative ibuprofen 400 mg
Trial: 26327799
Drug: Early post-operative
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early post-operative ibuprofen 400 mg
Trial: 20854173
Drug: Directly observed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Directly observed antiretroviral therapy (DOT)
Trial: 20832196
Drug: Self-administered therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administered therapy (Control)
Trial: 19018794
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of TAC and 5-fluorouracil (5-FU)
Trial: 3258429
Drug: Control (electrodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (electrodes applied daily but no stimulation)
Trial: 19925045
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Ramipril and Telmisartan
Trial: 31759587
Drug: Whipped cream
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Whipped cream
Trial: 18555224
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone (Endometrin 100 mg twice a day, n = 12; Endometrin 100 mg three times a day, n = 11; Crinone 8% gel 90 mg every day, n = 17)
Trial: 18555224
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) progesterone (50 mg every day, n = 200)
Trial: 28501869
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) progesterone
Trial: 17214405
Drug: Yohimbine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine (20 mg/day for 21 days)
Trial: 17214405
Drug: Placebo (cellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (cellulose tablets)
Trial: 12766655
Drug: Parasacral approach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parasacral approach with 20 ml ropivacaine, 0.75% (single bolus)
Trial: 12766655
Drug: Winnie's single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Winnie's single injection approach with 20 ml ropivacaine, 0.75% (single bolus)
Trial: 12766655
Drug: Winnie's double
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Winnie's double injection approach with 20 ml ropivacaine, 0.75% (10 ml plus 10 ml)
Trial: 8262828
Drug: Intraoperative radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoperative radiotherapy (IORT) at a dose of 25 Gy
Trial: 8262828
Drug: Intraoperative radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intraoperative radiotherapy (IORT) at a dose of 20 Gy or less
Trial: 8262828
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment of IORT and modified total esophagectomy
Trial: 3553433
Drug: Nifedipine 10
RxNorm normalized name: nifedipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 10 mg (t.i.d.)
Trial: 3553433
Drug: Nifedipine 20
RxNorm normalized name: nifedipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 20 mg (t.i.d.)
Trial: 24636210
Drug: Exemestane 25
RxNorm normalized name: exemestane 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exemestane 25 mg daily (T-scores < -2.0)
Trial: 24636210
Drug: Anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 1 mg daily (T-scores < -2.0)
Trial: 20404221
Drug: Bosentan 250
RxNorm normalized name: Bosentan
DrugBank: Bosentan (DB00559)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bosentan 250 mg daily
Trial: 20404221
Drug: Sitaxsentan 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitaxsentan 100 mg daily
Trial: 15990081
Drug: Travoprost 0.004%/timolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Travoprost 0.004%/timolol 0.5% fixed combination (Trav/Tim)
Trial: 10475291
Drug: Propofol 2‐mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2‐mg/kg bolus (i.v.)
Trial: 7815223
Drug: Heparin-bonded catheter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-bonded catheter
Trial: 27866765
Drug: SA3Ag vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SA3Ag vaccine
Trial: 27866765
Drug: SA4Ag and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SA4Ag and SA3Ag vaccines
Trial: 20877395
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment with 4 g of omega-3 fatty acids and 20 mg of simvastatin daily for 6 weeks
Trial: 20877395
Drug: Simvastatin monotherapy
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Simvastatin monotherapy of 20 mg daily for 6 weeks
Trial: 19359718
Drug: Toremifen 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toremifen 240 mg/day
Trial: 19359718
Drug: Toremifen 60
RxNorm normalized name: toremifene 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Toremifen 60 mg/day
Trial: 19359718
Drug: Letrozol 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozol 2.5 mg/day
Trial: 15111631
Drug: Pilocarpine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilocarpine (5 mg)
Trial: 7492129
Drug: 5% doxepin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% doxepin cream
Trial: 2049230
Drug: Streptokinase (SK)
DrugBank: Streptokinase (DB00086)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Streptokinase (SK) infused over 60 min at a dosage of 1.5 x 10(6) i.u.
Trial: 2049230
Drug: Anistreplase infused
RxNorm normalized name: Anistreplase
DrugBank: Anistreplase (DB00029)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anistreplase infused over 5 min at a dosage of 30 units
Trial: 6791393
Drug: Hypocaloric nutrition
RxNorm normalized name: Hydrochloric Acid
DrugBank: Hydrochloric acid (DB13366)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypocaloric nutrition (2 g CH/kg b.w.)
Trial: 6791393
Drug: Basic nutrition
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic nutrition (5 g CH/kg b.w.)
Trial: 6791393
Drug: Sole AA-substitution
RxNorm normalized name: English sole
DrugBank: English sole (DB10904)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sole AA-substitution (1 g AA/kg b.w.)
Trial: 31713753
Drug: Anodal tDCS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anodal tDCS combined with conventional swallowing therapy
Trial: 31713753
Drug: Sham tDCS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham tDCS combined with conventional swallowing therapy
Trial: 30625179
Drug: Energy Drink
RxNorm normalized name: Boost Energy Drink
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Energy Drink (250 ml containing 80 mg caffeine)
Trial: 15939243
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids (ICS) therapy
Trial: 22284563
Drug: Early ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Early ibuprofen treatment (n = 54)
Trial: 17620075
Drug: Grazax (75,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grazax (75,000 SQ-T, sublingual immunotherapy tablet)
Trial: 15790610
Drug: B-group vitamins
RxNorm normalized name: VITAMIN B
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: B-group vitamins (vitamin B1, 250 mg; vitamin B6, 250 mg; vitamin B12, 1000 microg twice daily) plus metformin (850 mg twice daily)
Trial: 15790610
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (174 microg twice daily) plus metformin (850 mg twice daily)
Trial: 11932303
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg pegvisomant